- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04500457
Exposure-Based Treatment for Perfectionism
July 25, 2023 updated by: Jesse Cougle, Florida State University
A Preliminary Evaluation of an Exposure-Based Treatment for Perfectionism
This study is examining the efficacy of a computerized, exposure-based, intervention for perfectionism.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The primary aim of this study is to evaluate the effects of a two-week computerized exposure-based treatment for perfectionism (ETP).
Individuals with elevated perfectionism will be randomly assigned to ETP or a waitlist (WL) control condition.
ETP will consist of three tasks in which they will repeatedly make mistakes, repeated for five sessions over a two-week period (one session every 3 days).
Study Type
Interventional
Enrollment (Actual)
76
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32306
- Florida State University, Department of Psychology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Score of at least 29 on the Frost Multidimensional Perfectionism Scale- Concern over Mistakes subscale
Exclusion Criteria:
- Current moderate or severe substance use disorder, psychotic disorder, or bipolar disorder
- Current suicidal ideation (imminent risk)
- Currently participating in psychotherapy
- Any changes to psychotropic medications in the past four weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
This arm consists of a 2-week computerized, exposure-based intervention.
Treatment sessions are completed every 3 days at home (5 treatment sessions total).
|
Three tasks focused on exposures are completed.
Each treatment session is approximately twenty minutes.
|
No Intervention: Wait-List Control
Participants in this condition will not receive treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frost Multidimensional Perfectionism Scale (FMPS)- Concern Over Mistakes Subscale
Time Frame: Levels of perfectionism from baseline to post treatment (2 weeks)
|
Self-report questionnaire examining levels of perfectionism.
The concern over mistakes sub-scale of the Frost Multidimensional Perfectionism Scale includes 9 items with scores on the sub-scale ranging from 9 to 45 (higher scores signify higher levels of concern over mistakes).
The concern over mistakes sub-scale includes the following items from the Frost Multidimensional Perfectionism Scale: 9, 10, 13, 14, 18, 21, 23, 25, 24.
Item scores are summed for a total sub-scale score.
|
Levels of perfectionism from baseline to post treatment (2 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Center for Epidemiological Studies Depression Scale (CES-D)
Time Frame: Depression symptoms from baseline to post treatment (2 weeks)
|
Self-report measure used to assess depressive symptoms.
Total scores range from 0 to 60 with higher scores indicating a higher level of depressive symptoms.
|
Depression symptoms from baseline to post treatment (2 weeks)
|
State-Trait Inventory for Cognitive and Somatic Anxiety-Trait Version (STICSA-T)
Time Frame: Anxiety symptoms from baseline to post treatment (2 weeks)
|
Self-report measure used to assess overall anxiety symptoms.
Scores range from 21 to 84 with higher scores indicating higher levels of overall anxiety.
|
Anxiety symptoms from baseline to post treatment (2 weeks)
|
Social Phobia Inventory (SPIN)
Time Frame: Social anxiety symptoms from baseline to post treatment (2 weeks)
|
Self-report scale that measures Social anxiety symptoms.
Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.
|
Social anxiety symptoms from baseline to post treatment (2 weeks)
|
Eating Attitudes Test (EAT-26)
Time Frame: Eating disorder symptoms from baseline to post treatment (2 weeks)
|
Self-report scale that measures eating disorder symptoms.
Scores range from 0 to 78 with higher scores indicating higher levels of eating disorder symptoms.
|
Eating disorder symptoms from baseline to post treatment (2 weeks)
|
Obsessive-Compulsive Inventory- Revised (OCI-R)
Time Frame: Obsessive-compulsiveness from baseline to post treatment (2 weeks)
|
Self-report scale that measures obsessive-compulsiveness.
Scores range from 0 to 72 with higher scores indicating higher levels of obsessive-compulsiveness.
|
Obsessive-compulsiveness from baseline to post treatment (2 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 3, 2019
Primary Completion (Actual)
February 26, 2021
Study Completion (Actual)
February 26, 2021
Study Registration Dates
First Submitted
August 3, 2020
First Submitted That Met QC Criteria
August 3, 2020
First Posted (Actual)
August 5, 2020
Study Record Updates
Last Update Posted (Actual)
July 27, 2023
Last Update Submitted That Met QC Criteria
July 25, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- HSC2019.27351
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perfectionism
-
Institute of Child HealthCompletedPerfectionismUnited Kingdom
-
Utah State UniversityRecruiting
-
Florida State UniversityActive, not recruitingPerfectionismUnited States
-
Istanbul Sabahattin Zaim UniversityCompletedPerfectionism | Intolerance to UncertaintyUnited States
-
Karolinska InstitutetUppsala University; University College, London; Linkoeping University; Stockholm...CompletedDepression | Stress | Anxiety | PerfectionismSweden
-
University of BergenCompleted
-
National University, SingaporeNot yet recruitingStress | Depression, Anxiety | Perfectionism | Shame | Self-Compassion
-
Universidad de GranadaChair in Conscience and Development (UGR); Mind, Brain and Behaviour Research...CompletedAnxiety | Psychological Distress | Perfectionism | Attention | Empathy | Creativity | Life Stress | Emotional IntelligenceSpain
-
University of SurreyCompletedCompassion | Perfectionism | Resilience | Rumination | Self-CriticismUnited Kingdom
Clinical Trials on Exposure-based Treatment for Perfectionism (ETP)
-
Florida State UniversityActive, not recruitingPerfectionismUnited States
-
Alzahra UniversityUnknown
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)Completed
-
University of BarcelonaNot yet recruitingAnxiety | Randomized Controlled Trial | Virtual Reality Exposure Therapy | AerophobiaSpain
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingAnorexia NervosaUnited States
-
Karolinska InstitutetRecruiting
-
University of ZurichUnknownUnipolar DepressionSwitzerland
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; University of BaselCompletedSomatoform Disorders | Globus HystericusSwitzerland
-
University of BarcelonaHospital Universitari de Bellvitge; Istituto Auxologico Italiano; Hospital Universitari... and other collaboratorsCompletedBinge-Eating Disorder | Bulimia Nervosa | Binge EatingSpain, Italy